Dr. Agarwal’s Health Care Limited has been issued a Show Cause Notice by the Office of the Assistant Commissioner, GST & Central Excise, regarding tax discrepancies for the 2022-23 financial year. The notice involves potential tax demands totaling Rs. 15.08 crores, along with applicable interest and penalties. The company is currently reviewing the notice and intends to submit a formal response within the prescribed 30-day timeframe.
Details of the Tax Notice
The company has received a formal communication from the tax authorities alleging various discrepancies in its filed returns for the 2022-23 financial year. The primary issues highlighted in the notice include differences in output turnover, short payments of tax under the Reverse Charge Mechanism, and potential inconsistencies related to input tax credit claims. Furthermore, the authorities have raised concerns regarding compliance with e-invoicing protocols and the reporting of exempted or non-GST supplies.
Financial and Operational Outlook
The total disputed amount mentioned in the notice stands at Rs. 15.08 crores, excluding potential interest and penalties that may be applied by the department. Dr. Agarwal’s Health Care Limited is currently in the process of thoroughly examining the order and preparing a comprehensive reply to address the specific allegations raised by the Assistant Commissioner.
Company Stance on Impact
Despite the receipt of this notice, the company has clarified that it does not anticipate any significant adverse impact on its financial stability, daily operations, or other core business activities. Management remains committed to responding within the required 30-day period to resolve the matter effectively.
Source: BSE
